|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.960 USD | +0.51% |
|
-5.31% | -67.97% |
Evolution of the Average Target: Actuate Therapeutics, Inc.
Evolution of the Target Price: Actuate Therapeutics, Inc.
Changes in Analyst Recommendations: Actuate Therapeutics, Inc.
2.4Ii1YIS32JDy8gXIWb1Z9-CC4Jozh5a0VbjPckTxdUQ.2MX3Fc3in-GtvGilG_8ruKLOlOJLy-XcJI2bFgLAAQ2W0uInzt6f2IaUQA~dfc6b1caf8a4b65019cd09c139b0b12e
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | +409.06% | |||||
| +11.16% | |||||
| +24.52% | |||||
| +37.62% | |||||
| +88.62% | |||||
| +41.58% | |||||
| +34.41% | |||||
| -24.16% | |||||
| -7.01% | |||||
| +32.73% | |||||
| Average | +64.85% | |||||
| Weighted average by Cap. | +26.66% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.960USD
Average target price
9.978USD
Spread / Average Target
+409.06%
High Price Target
14.91USD
Spread / Highest target
+660.71%
Low Price Target
5.000USD
Spread / Lowest Target
+155.10%
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| B. Riley |
SellBuy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.960USD
Average target price
9.978USD
Spread / Average Target
+409.06%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACTU Stock
- Consensus Actuate Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
